Skip to main content
logo
Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
42.43
-2.63 (-5.84%)
At close: Oct 28, 2026, 4:00 PM EDT
42.30
-0.13 (-0.31%)
After-hours: Oct 28, 2026, 7:59 PM EDT

Boston Scientific Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Cash & Equivalents
-5391,4531,9651,2755347254142,5022,9132,3298659524265709283382763251,925
Cash & Short-Term Investments
5395391,4531,9651,2755347254142,5022,9132,3298659524265709283382763251,925
Cash Growth (YoY)
-57.73%0.94%100.41%374.64%-49.04%-81.67%-68.87%-52.14%162.81%583.80%308.60%-6.79%181.66%54.35%75.39%-51.79%-82.64%-89.68%-83.88%11.02%
Accounts Receivable
-3,0493,0272,9262,8282,8152,6932,5582,5012,4002,3042,2282,1012,1342,0761,9701,8711,9171,8661,778
Receivables
-3,0493,0272,9262,8282,8152,6932,5582,5012,4002,3042,2282,1012,1342,0761,9701,8711,9171,8661,778
Inventory
-3,2353,1172,9432,9212,8612,8672,8102,7532,6082,5612,4842,4042,2502,0501,8671,7881,7521,7361,610
Restricted Cash
-81718098109103111707593130123135135149112132146188
Other Current Assets
-1,0681,0168809138029471,0279359958988079249418738461,0351,006992816
Total Current Assets
-7,9728,6848,7948,0357,1217,3356,9208,7618,9918,1856,5146,5045,8865,7045,7605,1445,0835,0656,317
Property, Plant & Equipment
-4,6794,6104,5014,2903,9533,8373,7433,4983,3673,3273,2983,0812,9792,8772,8322,6612,6462,6892,687
Long-Term Investments
-2,245705682642626654555532450429413427421385407389384406411
Goodwill
-18,64018,53618,28218,21418,07617,34017,08915,03314,39714,36114,38713,60813,65913,26912,92012,85212,88312,94911,988
Other Intangible Assets
-6,9187,0607,0197,1627,2606,5666,6845,7585,4305,8616,0035,8896,1126,1175,9696,1366,4376,6826,235
Long-Term Deferred Tax Assets
-3,9093,9533,6753,6693,7783,6763,6553,8163,8013,7923,8413,8403,8653,9003,9424,0184,0594,1024,142
Other Long-Term Assets
-853803720695745732749680672714680694679640639747697444449
Total Assets
-45,21644,35143,67342,70741,55940,14039,39538,07837,10836,66935,13634,04333,60132,89232,46931,94732,18932,33732,229

Liabilities

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Accounts Payable
-1,2311,1411,1441,0029621,004960907906921942929899868862803732696794
Accrued Expenses
-2,7562,5143,2012,7512,5932,1032,7732,2722,0271,7722,1361,9001,8581,6281,8551,7131,7051,6341,883
Current Portion of Long-Term Debt
-1,709412992884807771,7781,6521,5801,0855315135595102020170238261
Current Portion of Leases
---90195--81---76---61---71
Current Income Taxes Payable
----174173315-286224257220352400281232234257459209
Current Unearned Revenue
---313309313306306290284280266246242231220216222212208
Other Current Liabilities
-7328753926096695535015035556017626396045655535637971,036848
Total Current Liabilities
-6,4284,5715,4395,3285,1905,0586,3995,9105,5764,9164,9334,5794,5624,0833,8033,5493,8834,2754,274
Long-Term Debt
-10,79110,86411,01210,99210,98110,4068,8429,2298,9879,5308,5668,3828,4898,4908,9108,5598,7979,0618,798
Long-Term Leases
-124124571570566525527377369386395404406365352355362384395
Long-Term Unearned Revenue
---369359349335329328316314311301295290289278279279276
Long-Term Deferred Tax Liabilities
-22121922024222615815513813213213491135210144278265261310
Other Long-Term Liabilities
-2,4802,4691,5901,5861,5941,2131,1401,1401,1191,2231,2671,1571,2291,3451,3981,2881,3521,3421,554
Total Liabilities
-20,04418,24719,20119,07718,90617,69517,39217,12216,49916,50115,60614,91415,11614,78314,89614,30714,93815,60215,607

Shareholders' Equity

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Common Stock
-17171717171717171717171717171717171717
Additional Paid-In Capital
-21,71721,58421,50521,41921,23021,12721,05620,96320,80320,71320,64720,57320,44120,35620,28920,21920,10320,04319,986
Retained Earnings
-7,8186,9125,5714,8994,1443,3472,6732,1071,6391,314819315-189-450-750-876-1,050-1,296-1,392
Treasury Stock
--4,318-2,251-2,251-2,251-2,251-2,251-2,251-2,251-2,251-2,251-2,251-2,251-2,251-2,251-2,251-2,251-2,251-2,251-2,251
Comprehensive Income & Other
--304-398-609-690-722-28275-12816313350232208178268531432222262
Total Common Equity
24,93024,93025,86424,23323,39422,41822,21221,77020,70820,37119,92619,28218,88618,22617,85017,57317,64017,25116,73516,622
Minority Interest
-242240239236235233233248238242248243259259-----
Shareholders' Equity
25,17225,17226,10424,47223,63022,65322,44522,00320,95620,60920,16819,53019,12918,48518,10917,57317,64017,25116,73516,622
Total Liabilities & Equity
-45,21644,35143,67342,70741,55940,14039,39538,07837,10836,66935,13634,04333,60132,89232,46931,94732,18932,33732,229

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Total Debt
12,62412,62411,02911,97212,04512,02711,70811,22811,25810,93611,0019,5689,2999,4549,3659,3438,9349,3299,6839,525
Net Cash (Debt)
-12,085-12,085-9,576-10,007-10,770-11,493-10,983-10,814-8,756-8,023-8,672-8,703-8,347-9,028-8,795-8,415-8,596-9,053-9,358-7,600
Net Cash Growth (YoY)
--------------------
Net Cash Per Share
-8.32-8.19-6.41-6.69-7.20-7.70-7.36-7.26-5.89-5.41-5.85-5.89-5.66-6.20-6.08-5.83-5.97-6.30-6.51-5.29
Filing Date Shares Outstanding
1,4491,4491,4861,4841,4821,4821,4791,4761,4741,4731,4701,4671,4651,4641,4381,4351,4321,4321,4301,427
Total Common Shares Outstanding
1,4471,4471,4861,4831,4821,4801,4791,4751,4731,4711,4701,4661,4651,4631,4381,4331,4321,4301,4301,426
Working Capital
-1,5444,1133,3552,7071,9312,2775212,8513,4153,2691,5811,9251,3241,6211,9571,5951,2007902,043
Book Value Per Share
17.2317.2317.4016.3415.7815.1415.0214.7614.0513.8513.5613.1612.8912.4612.4212.2612.3212.0611.7111.66
Tangible Book Value
-628-628268-1,068-1,982-2,918-1,694-2,003-83544-296-1,108-611-1,545-1,536-1,316-1,348-2,069-2,896-1,601
Tangible Book Value Per Share
-0.43-0.430.18-0.72-1.34-1.97-1.15-1.36-0.060.37-0.20-0.76-0.42-1.06-1.07-0.92-0.94-1.45-2.03-1.12
Land
-183188173147147145144143140141140139141141137117118120109
Buildings
-2,7152,5182,4852,5362,1522,0962,0181,9121,8761,8561,8431,8011,7901,7631,6951,4611,4061,4151,523
Machinery
-4,0453,9163,8274,0373,9043,7813,6303,6733,5993,5503,5033,4503,4273,3663,2983,3723,4533,4913,288
Construction In Progress
-9111,1151,1619361,0411,0091,035966897880857691604567598513537539605
SEC Filings: 10-K · 10-Q